Don't miss

Replay


LATEST SHOWS

IN THE PAPERS

Is Hollande eyeing 'European Council president' post after he steps down?

Read more

IN THE PAPERS

11th hour: Scientists say primates facing 'imminent extinction'

Read more

EYE ON AFRICA

Regional troops gather at Gambian border amid political standoff

Read more

MEDIAWATCH

Online reactions to former French PM Valls being slapped in face

Read more

BUSINESS DAILY

Davos 2017: 'Donald Trump could be the entrepreneurs' entrepreneur'

Read more

THE DEBATE

Hard Brexit, here we come: The blowback against globalisation (part 2)

Read more

THE DEBATE

Hard Brexit, here we come: UK to leave EU common market (part 1)

Read more

THE DEBATE

Pardon my whistleblower: Obama commutes Chelsea Manning sentence (part 1)

Read more

THE DEBATE

Pardon my whistleblower: Obama, security and surveillance (part 2)

Read more

Business

GSK to cut 4,000 jobs in Europe and US

Text by News Wires

Latest update : 2010-01-31

Despite rising profits, British pharmaceuticals company GlaxoSmithKline is expected to announce a cut up to 4,000 more jobs. Most of the jobs cut will be in the United States and Europe.

AFP - British pharmaceuticals giant GlaxoSmithKline is to cut up to 4,000 more jobs as it restructures its workforce and focuses increasingly on emerging markets, The Sunday Times reported.
   
The majority of the jobs will be lost in the United States and Europe, the newspaper said.
   
GSK, which employs just under 100,000 staff globally, is expected to reveal plans for the job cuts when it releases its annual results on Thursday, the report said.
   
Its Anglo-Swedish rival AstraZeneca announced on Thursday it plans to axe 8,000 more jobs worldwide by 2014, extending a cost-cutting drive despite soaring profits.
   
While GSK is still seeking to develop new drugs, it is increasingly turning to emerging markets to find growth.
   
This led to it recently cutting 2,000 sales jobs in the United States while adding 1,500 staff in China.
   
The big players in the global pharmaceuticals industry are seeing their profits squeezed as they reduce their reliance on top-selling blockbuster drugs, many of whose patents will soon expire.

Date created : 2010-01-31

  • BENIN

    Chirac joins African leaders in calling for ban on fake drug sales

    Read more

COMMENT(S)